Table 2.
Protein | cDNA | n | Phenotype | Type | Domain | ADA2 activity (%WT) | Published phenotype [ref#] |
---|---|---|---|---|---|---|---|
G47W | c.139G>T | 1 | BMF | missense | Dimerization | 0.3 ± 0.5 | Vasculitis * 25 |
R49Afs*13 | c.137dupT | 4 | PRCA, BMF | frameshift | Dimerization | UD | Hemolytic anemia 8 |
F178S | c.533T>C | 2 | BMF | missense | Catalytic | 0.8 ± 0.6 | PRCA 8 |
F212del | c.634_636delTTC | 1 | BMF | deletion | Catalytic | 0.8 ± 1.2 | - |
G321E | c.962G>A | 1 | PRCA | missense | Catalytic | 1.8 ± 1.0 | BMF 18 |
G358R | c.1072G>A | 4 | BMF | missense | Catalytic | 1.7 ± 0.6 | PRCA 6 |
K449Nfs*2 | c.1346_1347insTT | 1 | BMF | frameshift | Catalytic | UD | - |
K466Tfs*2 | c.1397_1403AGGCTGAdel | 1 | BMF | frameshift | Catalytic | UD | PRCA 10 |
V458D | c.1373T>A | 1 | BMF | missense | Catalytic | 2.4 ± 0.4 | BMF 13 Vasculitis * 26 |
Abbreviations: UD, undetectable.
This mutation was previously described in a patient with compound heterozygous mutations.